Innoviva

INVA

Market cap $1.5B

20.00 USD

+0.25

1.27%

At close Updated Jan 30, 4:00 PM EST

Pre-market

After hours

20.02

+0.02

0.1%

1 day

1.27%

5 days

2.25%

1 month

0.55%

3 months

11.42%

6 months

8.52%

Year to date

0.65%

1 year

5.82%

5 years

62.34%

10 years

103.67%

About: Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Employees: 127

Healthcare Biotechnology